Search Results
May 05, 2026, 10:00 ET Services PMI® at 53.6%; April 2026 ISM® Services PMI® Report
and Dating Services). The data are weighted based on each industry's contribution to GDP. According to U.S. Bureau of Economic Analysis (BEA) estimates (the average of the fourth quarter 2024 GDP estimate and the GDP estimates for first, second, and third quarter 2025, as released on January 22, 2026),
More news about: Institute for Supply Management
May 05, 2026, 09:00 ET Hongli Group Inc. Announces Strategic Plan to Explore Opportunities in Clean Energy and Energy Storage Applications
important step for Hongli Group," said Mr. Jie Liu, Chief Executive Officer of Hongli Group. "With clean energy contributing more than 10% of China's GDP in 2024 and global policy initiatives targeting a significant expansion of renewable capacity by 2030, we intend to evaluate opportunities in solid-state
More news about: Hongli Group Inc.
May 01, 2026, 12:31 ET Curaleaf gibt die Berufung von Torsten Greif in den Vorstand bekannt
https://ir.curaleaf.com.Informationen zur Four 20 Pharma GmbHDie Four 20 Pharma GmbH ist ein führender, vollständig nach EU-GMP und GDP zugelassener europäischer Hersteller und Vertreiber von medizinischem Cannabis, der sich durch branchenführende Produktqualität und erstklassige regulatorische
More news about: Curaleaf Holdings, Inc.
May 01, 2026, 12:15 ET Curaleaf schließt den Erwerb der verbleibenden Anteile an der deutschen „Four 20 Pharma" ab
Four 20 Pharma GmbH abgeschlossen, einem deutschen Hersteller und Vertreiber von medizinischem Cannabis, der über eine vollständige EU-GMP- und GDP-Zulassung verfügt.Four 20 Pharma ist bekannt für seinen hochwertigen Anbau, die Verarbeitung in pharmazeutischer Qualität und sein flächendeckendes Vertriebsnetz
More news about: Curaleaf Holdings, Inc.
May 01, 2026, 10:00 ET Manufacturing PMI® at 52.7%; April 2026 ISM® Manufacturing PMI® Report
domestic product (GDP) contracted in April, compared to 16 percent in March, and the percentage of manufacturing GDP in strong contraction (defined as a composite PMI® of 45 percent or lower) decreased to 2 percent, compared to 4 percent in March. The share of sector GDP with a PMI®
More news about: Institute for Supply Management
May 01, 2026, 07:45 ET Curaleaf Announces Appointment of Torsten Greif to Board of Directors
https://ir.curaleaf.com.About Four 20 Pharma GmbHFour 20 Pharma GmbH is a leading, fully EU-GMP & GDP licensed European producer and distributor of medical cannabis with industry-leading product quality and best-in-class regulatory expertise. Four 20
More news about: Curaleaf Holdings, Inc.
May 01, 2026, 07:45 ET Curaleaf Announces Appointment of Torsten Greif to Board of Directors
https://ir.curaleaf.com.About Four 20 Pharma GmbHFour 20 Pharma GmbH is a leading, fully EU-GMP & GDP licensed European producer and distributor of medical cannabis with industry-leading product quality and best-in-class regulatory expertise. Four 20
More news about: Curaleaf Holdings, Inc.
Apr 30, 2026, 17:16 ET 哥斯達黎加設新加坡辦事處 加強競逐亞洲投資
表示：「哥斯達黎加正推行一項具前瞻視野的宏大策略，將自身定位為高價值投資的首選目的地。 我們會主動出擊，不會坐等機遇。 我們在新加坡設立據點正反映這項策略，在亞太區建立強大的營運基礎，擴大全球影響力，並直接與全球供應鏈中的關鍵參與者互動。 我們透過提供穩定基礎、世界級人才及促進長期增長的可靠商業環境，爭取尖端產業進駐。」選址新加坡乃經深思熟慮。 該國本地生產總值 (GDP) 超過 5,000 億美元，且擁有成熟的金融、物流和科技樞紐地位，是企業管理日本、南韓及東南亞等關鍵市場業務的門戶。 許多涉及半導體、電子、先進製造及全球服務等領域的重大投資決策，均在新加坡作出。Laura López Salazar 表示：「分散外來直接投資來源非常重要，有助維持增長、減少受全球波動影響及為哥斯達黎加人才創造更多機會。
More news about: PROCOMER
Apr 30, 2026, 16:30 ET Curaleaf Completes Buyout of Remaining Stake in Germany's Four 20 Pharma
Four 20 Pharma GmbH, a fully EU-GMP and GDP licensed German producer and distributor of medical cannabis. Four 20 Pharma is recognized for its high-quality cultivation, pharmaceutical-grade processing,
More news about: Curaleaf Holdings, Inc.
Apr 30, 2026, 16:30 ET Curaleaf Completes Buyout of Remaining Stake in Germany's Four 20 Pharma
Four 20 Pharma GmbH, a fully EU-GMP and GDP licensed German producer and distributor of medical cannabis. Four 20 Pharma is recognized for its high-quality cultivation, pharmaceutical-grade processing,
More news about: Curaleaf Holdings, Inc.
Apr 30, 2026, 12:54 ET WORLD BUSINESS CHICAGO RELEASES ANNUAL "STATE OF THE ECONOMY" REPORT
economic development, including:The growing importance of industry diversification, with no single sector exceeding 13% of regional GDPContinued strength in core industries such as manufacturing, logistics, finance, and professional servicesRising momentum in future-facing
More news about: World Business Chicago
Apr 30, 2026, 10:05 ET Rising Demand for Advanced Wound Care and Hygiene Products Drives Hydrogel Market Growth to US$ 59.9 Bn by 2033 | Persistence Market Research
systems and strong institutional demand for wound care and medical-grade applications. The region benefits from healthcare spending exceeding 17% of GDP in the U.S., supporting sustained procurement of premium hydrogel-based products. Strict FDA regulations ensure rigorous clinical validation, which strengthens
More news about: Persistence Market Research Pvt. Ltd.
Apr 30, 2026, 10:00 ET The Conference Board Leading Economic Index® (LEI) for the US Declined in March After Increasing in February
remain modest, as weaker consumer spending offsets some strength in business investment and defense-related activity. The Conference Board revised its US GDP growth forecast to well below 2%, down to 1.6% y/y for 2026."The Conference Board Coincident Economic Index® (CEI) for the US was unchanged
More news about: The Conference Board
Apr 30, 2026, 07:00 ET Bandwidth Announces First Quarter 2026 Financial Results
voice calling, text messaging and emergency services. Our solutions and our Communications Cloud, covering 65+ countries and over 90 percent of global GDP, are trusted by all the leaders in unified communications and cloud contact centers–including Amazon Web Services (AWS), Cisco, Google, Microsoft, RingCentral,
More news about: Bandwidth Inc.
Apr 29, 2026, 23:31 ET 德昇濟醫藥在AACR 2026大會公佈KRAS管線最新進展；新一代KRAS G12C抑制劑Elisrasib（D3S-001）在多瘤種中展現出強勁II期療效
G12C突變腫瘤的重要基礎治療方案。」關於Elisrasib（D3S-001）Elisrasib 是一款新一代 KRAS G12C 抑制劑，旨在實現快速、充分且選擇性的靶點結合。該藥物可與 KRAS G12C 的 GDP 結合（OFF）構象發生共價結合，從而有效阻斷核甘酸循環並抑制致癌信號通路。臨床前研究顯示其具有強效活性，在臨床相關暴露水平下可實現完全的 KRAS G12C 靶點佔領，並具備中樞神經系統（CNS）滲透能力。Elisrasib 目前正在全球範圍內開展 II 期單藥及聯合治療研究，覆蓋 KRAS G12C
More news about: 德昇濟醫藥（D3 Bio）
Apr 29, 2026, 23:13 ET D3 Bio Presents KRAS Pipeline Updates at AACR 2026; Elisrasib (D3S-001), a Next-Generation KRAS G12C Inhibitor, Shows Strong Phase 2 Efficacy Across Multiple Tumor Types
(D3S-001)Elisrasib is a next-generation KRAS G12C inhibitor designed for rapid, complete, and selective target engagement. It covalently binds the GDP-bound (OFF) form of KRAS G12C, effectively blocking nucleotide cycling and suppressing oncogenic signaling. Preclinical studies show robust potency,
More news about: D3 Bio
Apr 29, 2026, 09:39 ET When Oil Prices Rise, the Economy Feels the Pressure
States.Economic growth can slow when energy costs surge. Research suggests that a meaningful rise in oil prices can shave measurable points off GDP growth as businesses reduce investment and consumers delay major purchases.Yet the relationship is complex. The United States is both a major
More news about: Precise Financial Solutions
Apr 29, 2026, 03:40 ET UPM Interim Report Q1 2026: Good start to the year - excellent performance in decarbonization solutions
advanced materials and renewable fibres. All these businesses operate in growing markets and have a strong combined track record of realized growth above GDP.Disruptions in the fossil fuel markets underscore the importance of renewable alternatives, not only for mitigating climate change but also for
More news about: UPM-Kymmene Oyj
Apr 28, 2026, 19:53 ET Global Times: From seawater to green hydrogen, and beyond, Qingdao charts a new growth path
output reached nearly 11.02 trillion yuan ($1.62 trillion), with a year-on-year growth of 5.5 percent, and accounting for 7.9 percent of the country's GDP. Utilizing its inherent resources and technological innovation, Qingdao is a prime example of China's efforts to promote the high-quality development
More news about: Global Times
Apr 28, 2026, 11:05 ET New Research from HACE with Nearly 1,000 Respondents Reveals the Real Cost of the Latino Leadership Gap -- and a Proven Path to Close It
StrongerThe opportunity is significant:Latino buying power exceeds $3T and is projected to reach $5.1T by 2030U.S. Latino GDP is $4.1T — the world's fifth-largest economyLatinos are the fastest-growing workforce demographicYet, 67% of Latino professionals
More news about: Hispanic Alliance for Career Enhancement (HACE)
Apr 28, 2026, 10:16 ET OpenRoad Insurance: Is Now the Right Time to Buy a Classic Car? The Data Says Yes
geopolitical environment. The US-Israeli war with Iran and the ongoing war between Ukraine and Russia have created significant risk for financial markets. US GDP grew at only 0.5% in the fourth quarter of 2025 — a sharp deceleration from 4.4% growth in Q3. Unemployment is up slightly year-over-year at 4.3%, and
More news about: Open Road Insurance
Apr 28, 2026, 07:00 ET Honeywell Announces Board of Directors for Honeywell Aerospace
such as changes in or application of trade and tax laws and policies, including the impacts of tariffs and other trade barriers and restrictions, lower GDP growth or recession in the U.S. or globally, supply chain disruptions, capital markets volatility, inflation, and certain regional conflicts, that can
More news about: Honeywell
Apr 28, 2026, 06:00 ET Nokia, Blaize, and Datacomm Diangraha Unite to Deliver Hybrid AI Inference Across Indonesia and Southeast Asia
PointThe AI opportunity in Indonesia is accelerating fast. Sovereign AI alone is forecast to add up to USD $140 billion to the country's GDP by 2030, equivalent to annual economic growth of up to 6.8%, according to the Empowering Indonesia Report 2025 by Indosat Ooredoo Hutchison and
More news about: Blaize Inc.
Apr 27, 2026, 13:45 ET HONEYWELL ANNOUNCES QUARTERLY DIVIDEND
such as changes in or application of trade and tax laws and policies, including the impacts of tariffs and other trade barriers and restrictions, lower GDP growth or recession in the U.S. or globally, supply chain disruptions, capital markets volatility, inflation, and certain regional conflicts, including
More news about: Honeywell
Apr 27, 2026, 07:00 ET Solstice Advanced Materials Declares Dividend of $0.075 per Common Share
such as changes in or application of trade and tax laws and policies, including the impacts of tariffs and other trade barriers and restrictions, lower GDP growth or recession in the U.S. or globally, supply chain disruptions, capital markets volatility, and inflation, that can affect Solstice's performance
More news about: Solstice Advanced Materials US, Inc.